We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA granted expedited review to Humacyte’s tissue therapy under the new Regenerative Medicine Advanced Therapy pathway — one of the first products to receive the designation established by the 21st Century Cures Act. Read More
The FDA said it will delay its “intended use” rule governing when tobacco products are to be classified as drugs, devices or combination products. Read More
Four former FDA commissioners have called on Congress to abandon proposals that would allow drug imports, warning that such measures would come with substantial risks and only have a small effect on prescription drug costs and access. Read More
The EU Court of Justice has denied the European Medicines Agency appeals to allow the agency to release documents as part of its transparency efforts. Read More